3//SEC Filing
KNIGHT THERAPEUTICS INTERNATIONAL SA 3
Accession 0001140361-23-058049
CIK 0001946563other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 9:23 AM ET
Size
19.6 KB
Accession
0001140361-23-058049
Insider Transaction Report
Form 3
Knight Therapeutics (Barbados) Inc.
10% Owner
Holdings
- 1,108,337(indirect: By Knight Therapeutics International SA)
Common Stock, $0.0001 par value per share ("Common Shares")
Knight Therapeutics Inc
10% Owner
Holdings
- 1,108,337(indirect: By Knight Therapeutics International SA)
Common Stock, $0.0001 par value per share ("Common Shares")
Footnotes (3)
- [F1]In addition to Knight Therapeutics Inc., a Canadian corporation ("Knight Parent"), this Form 3 is being jointly filed by Knight Therapeutics International S.A., an Uruguayan corporation ("Knight Subsidiary" and collectively with Knight Parent, the "Reporting Persons").
- [F2]Knight Subsidiary directly beneficially owns 1,108,337 Common Shares.
- [F3]Knight Parent is the sole owner of Knight Subsidiary and, as a result, may be deemed the beneficial owner for purposes of Securities Exchange Act of 1934 (the "Act") of any securities of 60 Degrees Pharmaceuticals, Inc. (the "Issuer") beneficially owned by Knight Subsidiary. Knight Parent disclaims beneficial ownership over all of the Common Shares beneficially owned by Knight Subsidiary, other than for the purpose of determining obligations under the Act, and the filing of this Form 3 shall not be deemed an admission that Knight Parent is the beneficial owner of such securities for any other purpose.
Documents
Issuer
60 DEGREES PHARMACEUTICALS, INC.
CIK 0001946563
Entity typeother
IncorporatedUruguay
Related Parties
1- filerCIK 0001632373
Filing Metadata
- Form type
- 3
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 9:23 AM ET
- Size
- 19.6 KB